Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PX domain-containing protein kinase-like protein (PXK) is a multi-domain protein characterized by a PX domain—which targets it to endosomal membranes—a protein kinase-like domain, and a WASP homology 2 domain[1][8]. PXK regulates membrane protein trafficking, specifically accelerating ligand-induced internalization and degradation of epidermal growth factor receptors via enhanced ubiquitination, and modulates Na,K-ATPase subunits in the brain, impacting electrical excitability and synaptic transmission[1][4][5][6][7]. Although structurally similar to kinases, PXK’s kinase activity is considered atypical, and its main molecular functions relate to protein trafficking and modulation rather than classical phosphorylation signaling[8]. PXK has been associated genetically with systemic lupus erythematosus, but no drugs are currently documented to target PXK directly. Its role in neuronal regulation and immune disease makes it a protein of therapeutic interest and a possible disease biomarker[6].
Null (no drugs documented to target PXK directly).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PX domain-containing protein kinase-like protein (PXK).